Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Nanoparticle breakthrough opens new doors for disease treatment

Nanoparticle breakthrough opens new doors for disease treatment

19th November 2012

Scientists at Northwestern University have developed a biodegradable nanoparticle that can potentially be used to treat multiple sclerosis (MS) and other diseases in a new way.

Tests using mice have revealed that this particle can be used as a vehicle to deliver an antigen that can cause the immune system to stop attacking myelin, resetting its functions to normal and preventing relapsing remitting MS.

It is the first MS therapy that does not function by suppressing the immune system, meaning it could be a much safer and more effective means of treating the disease.

Researchers believe the particle can also be used against a wide variety of immune-mediated diseases, including type 1 diabetes, food allergies and airway allergies such as asthma.

Study author Stephen Miller at Northwestern University Feinberg School of Medicine said: "This is a highly significant breakthrough in translational immunotherapy. The beauty of this new technology is it can be used in many immune-related diseases. We simply change the antigen that's delivered."

This could be a major breakthrough for sufferers of MS, of which there are estimated to be around 100,000 in the UK.ADNFCR-8000103-ID-801490920-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.